retatrutide glp-1 receptor agonist Scott Isaacs on X: "#retatrutide is a novel triple peptide at the glucagon receptor, GIP receptor, and receptor. 22-24% weight loss at 48 weeks with a similar tolerability profile to # PDB-101: Molecule of the Month:
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
















-1775582746855.png&w=3840&q=75)








